🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Peter A. Kaufman

University of Vermont

ORCID: 0000-0003-3677-6807
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer”.

Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0112
N/A
0.523DataRank · unranked
8 citations

Peter A. Kaufman, Karthik V. Giridhar, Jonathan D. Marotti, Mary D. Chamberlin, Bradley A. Arrick +7 more

Alliance A071701: Genomically guided treatment trial in brain metastases.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps2573
N/A
0.444DataRank · unranked
7 citations

Erin Twohy, Carey K. Anders, A. John Iafrate, Peter A. Kaufman, Justine V. Cohen +11 more

EFFECTS OF NONVERBAL BEHAVIOR ON STUDENT ATTITUDES IN THE COLLEGE CLASSROOM

The Humanist Educator(1975)10.1002/j.2164-6163.1975.tb00192.x
N/A
0.269DataRank · unranked
5 citations

Peter A. Kaufman, James M. Seals

Imlunestrant, an oral selective estrogen receptor degrader, in combination with HER2 directed therapy, with or without abemaciclib, in ER-positive, HER2-positive advanced breast cancer: results from the phase 1a/1b EMBER study

Breast Cancer Research(2025)10.1186/s13058-025-02168-6
N/A
0.173DataRank · unranked
2 citations

Komal L. Jhaveri, Peter A. Kaufman, Philippe Aftimos, Janine Lombard, Karthik V. Giridhar +13 more

Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.0166
N/A
0DataRank · unranked
2 citations

Shuai Chen, Diana L. Miglioretti, Charlotte C. Gard, Jeffrey A. Tice, Rebecca A. Hubbard +4 more

Near-Infrared Spectral Tomography for Predicting Residual Cancer Burden during Early-Stage Neoadjuvant Chemotherapy for Breast Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1593
N/A
0DataRank · unranked
5 citations

Kristen E. Muller, Mary D. Chamberlin, Jiang Gui, Peter A. Kaufman, Gary N. Schwartz +5 more

Smoking, e-cigarettes and the effect on respiratory symptoms among a population sample of youth: retrospective study

medRxiv(2022)10.1101/2022.03.10.22272186
N/A
0DataRank · unranked
2 citations

Martin Pienkowski, Iman Musani, Susan J. Bondy, Cohen Je, Jolene Dubray +5 more

Milestones in the natural course of the onset of e-cigarette dependence among adolescents and young adults: Retrospective study

Addictive Behaviors(2023)10.1016/j.addbeh.2023.107846
N/A
0DataRank · unranked
6 citations

Michael Chaiton, Susan J. Bondy, Joanna E Cohen, Jolene Dubray, Thomas Eissenberg +6 more

Effect of neuromuscular electrical stimulation on skeletal muscle size and function in patients with breast cancer receiving chemotherapy

Journal of Applied Physiology(2020)10.1152/japplphysiol.00203.2020
N/A
0DataRank · unranked
30 citations

Thomas B. Voigt, Timothy W. Tourville, Shannon M. Prior, Blas A. Guigni, Axel V. Schlosberg +7 more